Talk politics.

Well, the DEA action in that post is actually to increase the availability of synthetic THC (http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2010/11/redefining-dronabinol-part-deux.html) by allowing more formulations and generics other than the single approved formula. It's certainly hypocritical, but the Big Pharma conspiracy is difficult to pinpoint. Part of the problem is that the DEA's hands are tied by Congress. It can argue the eight statutory factors for Schedule certification all it likes, but pot possession and distribution has a clear statutory bar in 21 U.S.C. 841(b).